Editas Medicine (EDIT) PT Lowered to $35 at Chardan Capital Markets
Tweet Send to a Friend
Chardan Capital Markets analyst Geulah ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
